- $1.53bn
- $1.30bn
- $1.62bn
- 87
- 83
- 28
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,222 | 598 | 865 | 1,602 | 1,617 |
Cost of Revenue | |||||
Gross Profit | 303 | 118 | 202 | 514 | 528 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,337 | 908 | 849 | 1,314 | 1,373 |
Operating Profit | -114 | -310 | 16.3 | 288 | 245 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -113 | -309 | 16.4 | 290 | 256 |
Provision for Income Taxes | |||||
Net Income After Taxes | -87.1 | -212 | 7.22 | 218 | 195 |
Net Income Before Extraordinary Items | |||||
Net Income | -87.1 | -212 | 7.22 | 218 | 195 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -87.1 | -212 | 7.22 | 215 | 192 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.168 | -0.362 | 0.011 | 0.988 | 0.934 |
Dividends per Share |